Celularity (CELUW) EPS (Weighted Average and Diluted) (2020 - 2025)
Celularity (CELUW) reported EPS (Weighted Average and Diluted) of -$0.85 for Q4 2025, down 44.07% year-over-year from -$1.52 in Q4 2024, and up 3.41% quarter-over-quarter from -$0.88 in Q3 2025.
Celularity (CELUW) EPS (Weighted Average and Diluted) (2020 - 2025) Analysis & Trends
Celularity (CELUW) has 6 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.85 in Q4 2025.
- EPS (Weighted Average and Diluted) for Q4 2025 came in at -$0.85, down 44.07% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3.59 (down 35.47% YoY), and the FY2025 annual result was -$3.59, down 35.98% from the prior year.
- EPS (Weighted Average and Diluted) climbed to -$0.85 in Q4 2025 per CELUW's latest filing, from -$0.88 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $1.02 in Q4 2022 and troughed at -$4.98 in Q3 2023.
- A 5-year average of -$0.95 and a median of -$0.73 in 2024 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2021 and 2023: EPS (Weighted Average and Diluted) jumped 115.87% in 2021, then sank 16700.0% in 2023.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.51 in 2021, then jumped by 100.0% to $1.02 in 2022, then declined by 17.65% to $0.84 in 2023, then plunged by 170.24% to -$0.59 in 2024, then tumbled by 44.07% to -$0.85 in 2025.
- Business Quant data shows CELUW's EPS (Weighted Average and Diluted) at -$0.85 in Q4 2025, -$0.88 in Q3 2025, and -$1.02 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Celularity | - | - | -3.27 Mn | -0.85 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.85 |
| Sep 30, 2025 | -0.88 |
| Jun 30, 2025 | -1.02 |
| Mar 31, 2025 | -0.84 |
| Dec 31, 2024 | -0.59 |
| Sep 30, 2024 | -0.73 |
| Jun 30, 2024 | -0.30 |
| Mar 31, 2024 | -1.03 |
| Dec 31, 2023 | 0.84 |
| Sep 30, 2023 | -4.98 |
| Jun 30, 2023 | -2.72 |
| Mar 31, 2023 | -4.12 |
| Dec 31, 2022 | 1.02 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.32 |
| Mar 31, 2022 | -0.48 |
| Dec 31, 2021 | 0.51 |
| Sep 30, 2021 | 0.40 |
| Jun 30, 2021 | -2.69 |
| Sep 30, 2020 | -2.52 |